|
|
||||||||



* Department of Anatomy and Developmental Biology,
Cellular Microbiology Research Group, Eastman Dental Institute, and
Autonomic Neuroscience Institute, University College London, London WC1E 6BT, U.K.
1Correspondence: Department of Anatomy and Developmental Biology, University College London, London WC1E 6BT, U.K. E-mail: t.arnett{at}ucl.ac.uk
There is increasing evidence that extracellular nucleotides act on bone cells via P2 receptors. This study investigated the action of ADP and 2-methylthioADP, a potent ADP analog with selectivity for the P2Y1 receptor, on osteoclasts, the bone-resorbing multinuclear cells. Using three different assays, we show that ADP and 2-methylthioADP at nanomolar to submicromolar levels caused up to fourfold to sixfold increases in osteoclastic bone resorption. On mature rat osteoclasts, cultured for 1 day on polished dentine disks, peak effects on resorption pit formation were observed between 20 nM and 2 µM of ADP. The same concentrations of ADP also stimulated osteoclast and resorption pit formation in 10-day mouse marrow cultures on dentine disks. In 3-day explant cultures of mouse calvarial bones, the stimulatory effect of ADP on osteoclast-mediated Ca2+ release was greatest at 550 µM and equivalent to the maximal effects of prostaglandin E2. The ADP effects were blocked in a nontoxic manner by MRS 2179, a P2Y1 receptor antagonist. Using in situ hybridization and immunocytochemistry, we found evidence for P2Y1 receptor expression on both osteoclasts and osteoblasts; thus, ADP could exert its actions both directly on osteoclasts and indirectly via P2Y1 receptors on osteoblasts. As a major ATP degradation product, ADP is a novel stimulator of bone resorption that could help mediate inflammatory bone loss in vivo.Hoebertz, A., Meghji, S., Burnstock, G., Arnett, T. Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y1 receptor on bone cells.
Key Words: P2 receptors ADP ATP osteoclast bone resorption P2Y1
This article has been cited by other articles:
![]() |
T. R. Arnett Extracellular pH Regulates Bone Cell Function J. Nutr., February 1, 2008; 138(2): 415S - 418S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Burnstock Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev., March 1, 2006; 58(1): 58 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Korcok, L. N. Raimundo, X. Du, S. M. Sims, and S. J. Dixon P2Y6 Nucleotide Receptors Activate NF-{kappa}B and Increase Survival of Osteoclasts J. Biol. Chem., April 29, 2005; 280(17): 16909 - 16915. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. BUCKLEY, S. L. GOLDING, J. M. RICE, J. P. DILLON, and J. A. GALLAGHER Release and interconversion of P2 receptor agonists by human osteoblast-like cells FASEB J, August 1, 2003; 17(11): 1401 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. North Molecular Physiology of P2X Receptors Physiol Rev, October 1, 2002; 82(4): 1013 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Naemsch, S. J. Dixon, and S. M. Sims Activity-dependent Development of P2X7 Current and Ca2+ Entry in Rabbit Osteoclasts J. Biol. Chem., October 12, 2001; 276(42): 39107 - 39114. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |